Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Digging for data from the COX-2 trials.

× No keyword cloud information.

6 in total

1. FDA refuses companies' request to drop ulcer warning.

Authors: S Gottlieb
Journal: BMJ Date: 2001-02-17

2. Reporting drug safety in clinical trials: getting the emphasis right.

Authors: J C Mucklow
Journal: Lancet Date: 2001-05-05 Impact factor: 79.321

3. Inaccessibility of drug reports.

Authors: Joel Lexchin
Journal: CMAJ Date: 2002-05-14 Impact factor: 8.262

Review 4. Understanding controlled trials. Why are randomised controlled trials important?

Authors: B Sibbald; M Roland
Journal: BMJ Date: 1998-01-17

5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors: F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal: JAMA Date: 2000-09-13 Impact factor: 56.272

6. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors: C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal: N Engl J Med Date: 2000-11-23 Impact factor: 91.245

6 in total

5 in total

1. Use of a once-daily NSAID in treatment of cyclic vomiting syndrome.

Authors: Mahesh K Vidula; Anil Wadhwani; Kaleigh Roberts; Lyle L Berkowitz
Journal: J Gen Intern Med Date: 2013-10-16 Impact factor: 5.128

Review 2. Reporting bias in medical research - a narrative review.

Authors: Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal: Trials Date: 2010-04-13 Impact factor: 2.279

Review 3. The double-edged sword of COX-2 selective NSAIDs.

Authors: James M Wright
Journal: CMAJ Date: 2002-11-12 Impact factor: 8.262

4. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).

Authors: Eric Wooltorton
Journal: CMAJ Date: 2002-06-25 Impact factor: 8.262

5. Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

Authors: James P McCormack; G Michael Allan
Journal: PLoS Med Date: 2010-02-02 Impact factor: 11.069

5 in total